The global topical drug delivery market size is expected to reach around US$ 172.54 billion by 2030 from US$ 96 billion in 2021 and is expected to grow at an impressive double-digit rate of 6.7% from 2022 to 2030.
The study includes drivers and restraints of this market. The study provides an analysis of the global topical drug delivery market for the period 2017-2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.
Key factors that propels the topical drug delivery market includes burn injuries and high frequency of skin conditions, deep drugs penetration in human body, surge in preference towards topical drug delivery owing to its nature of non-invasiveness, and surge in senior population. Factors similar as biologics deliveries via the transversal route and accession of small key players are anticipated to present myriad opportunities for market growth in near future.
Download Free Sample Copy Here (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1561
COVID-19 Impact Analysis:
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Social distancing and restrictions severely disrupted businesses and operations
- Took a toll on the economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- The emergence of variants continue to cause concerns and impact normal routines
Why should you invest in this report?
If you are aiming to enter the global topical drug delivery market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for topical drug delivery are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global topical drug delivery market include:
- Johnson & Johnson
- Novartis International AG
- F. Hoffmann-La Roche AG
- Pfizer Inc.
- Bayer AG
- Antares Pharma, Inc.
- GlaxoSmithKline plc
- 3M (US), Merck & Co., Inc.
- Sanofi
- Amgen, Inc.
Segments Covered in the Report
By Product
- Semi-Solid Formulations
- Creams
- Ointments
- Lotions
- Gels
- Pastes
- Liquid Formulations
- Solutions
- Suspensions
- Solid Formulations
- Powders
- Suppositories
- Transdermal Products
- Transdermal Patches
- Transdermal Semi-solids
By Route of Administration
- Oral
- Injectable
- Topical
- Ocular
- Pulmonary
- Implantable
- Transmucosal
- Nasal
By Application
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Respiratory Diseases
- Central Nervous System Disorders
- Autoimmune Diseases
- Other Applications
By End User
- Home Care Settings
- Hospitals & Clinics
- Burn Centers
- Other Facilities
Regional Analysis:
The geographical analysis of the global topical drug delivery market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global topical drug delivery Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global topical drug delivery market in 2030?
- What is the expected CAGR for the topical drug delivery market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global topical drug delivery market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Topical Drug Delivery Market
5.1. COVID-19 Landscape: Topical Drug Delivery Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Topical Drug Delivery Market, By Product
8.1. Topical Drug Delivery Market, by Product Type, 2021-2030
8.1.1. Semi-Solid Formulations
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Liquid Formulations
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Solid Formulations
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Transdermal Products
8.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Topical Drug Delivery Market, By Route of Administration
9.1. Topical Drug Delivery Market, by Route of Administration, 2021-2030
9.1.1. Oral
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Injectable
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Topical
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Ocular
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Pulmonary
9.1.5.1. Market Revenue and Forecast (2019-2030)
9.1.6. Implantable
9.1.6.1. Market Revenue and Forecast (2019-2030)
9.1.7. Transmucosal
9.1.7.1. Market Revenue and Forecast (2019-2030)
9.1.8. Nasal
9.1.8.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Topical Drug Delivery Market, By Application
10.1. Topical Drug Delivery Market, by Application, 2021-2030
10.1.1. Infectious Diseases
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Cancer
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Cardiovascular Diseases
10.1.3.1. Market Revenue and Forecast (2019-2030)
10.1.4. Diabetes
10.1.4.1. Market Revenue and Forecast (2019-2030)
10.1.5. Respiratory Diseases
10.1.5.1. Market Revenue and Forecast (2019-2030)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Topical Drug Delivery Market, By End User
11.1. Topical Drug Delivery Market, by End User, 2021-2030
11.1.1. Home Care Settings
11.1.1.1. Market Revenue and Forecast (2019-2030)
11.1.2. Hospitals & Clinics
11.1.2.1. Market Revenue and Forecast (2019-2030)
11.1.3. Burn Centers
11.1.3.1. Market Revenue and Forecast (2019-2030)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 12. Global Topical Drug Delivery Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.2. Market Revenue and Forecast, by Route of Administration (2019-2030)
12.1.3. Market Revenue and Forecast, by Application (2019-2030)
12.1.4. Market Revenue and Forecast, by End User (2019-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.5.2. Market Revenue and Forecast, by Route of Administration (2019-2030)
12.1.5.3. Market Revenue and Forecast, by Application (2019-2030)
12.1.5.4. Market Revenue and Forecast, by End User (2019-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.6.2. Market Revenue and Forecast, by Route of Administration (2019-2030)
12.1.6.3. Market Revenue and Forecast, by Application (2019-2030)
12.1.6.4. Market Revenue and Forecast, by End User (2019-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.2. Market Revenue and Forecast, by Route of Administration (2019-2030)
12.2.3. Market Revenue and Forecast, by Application (2019-2030)
12.2.4. Market Revenue and Forecast, by End User (2019-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.5.2. Market Revenue and Forecast, by Route of Administration (2019-2030)
12.2.5.3. Market Revenue and Forecast, by Application (2019-2030)
12.2.5.4. Market Revenue and Forecast, by End User (2019-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.6.2. Market Revenue and Forecast, by Route of Administration (2019-2030)
12.2.6.3. Market Revenue and Forecast, by Application (2019-2030)
12.2.6.4. Market Revenue and Forecast, by End User (2019-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.7.2. Market Revenue and Forecast, by Route of Administration (2019-2030)
12.2.7.3. Market Revenue and Forecast, by Application (2019-2030)
12.2.7.4. Market Revenue and Forecast, by End User (2019-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.8.2. Market Revenue and Forecast, by Route of Administration (2019-2030)
12.2.8.3. Market Revenue and Forecast, by Application (2019-2030)
12.2.8.4. Market Revenue and Forecast, by End User (2019-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.2. Market Revenue and Forecast, by Route of Administration (2019-2030)
12.3.3. Market Revenue and Forecast, by Application (2019-2030)
12.3.4. Market Revenue and Forecast, by End User (2019-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.5.2. Market Revenue and Forecast, by Route of Administration (2019-2030)
12.3.5.3. Market Revenue and Forecast, by Application (2019-2030)
12.3.5.4. Market Revenue and Forecast, by End User (2019-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.6.2. Market Revenue and Forecast, by Route of Administration (2019-2030)
12.3.6.3. Market Revenue and Forecast, by Application (2019-2030)
12.3.6.4. Market Revenue and Forecast, by End User (2019-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.7.2. Market Revenue and Forecast, by Route of Administration (2019-2030)
12.3.7.3. Market Revenue and Forecast, by Application (2019-2030)
12.3.7.4. Market Revenue and Forecast, by End User (2019-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.8.2. Market Revenue and Forecast, by Route of Administration (2019-2030)
12.3.8.3. Market Revenue and Forecast, by Application (2019-2030)
12.3.8.4. Market Revenue and Forecast, by End User (2019-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.2. Market Revenue and Forecast, by Route of Administration (2019-2030)
12.4.3. Market Revenue and Forecast, by Application (2019-2030)
12.4.4. Market Revenue and Forecast, by End User (2019-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.5.2. Market Revenue and Forecast, by Route of Administration (2019-2030)
12.4.5.3. Market Revenue and Forecast, by Application (2019-2030)
12.4.5.4. Market Revenue and Forecast, by End User (2019-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.6.2. Market Revenue and Forecast, by Route of Administration (2019-2030)
12.4.6.3. Market Revenue and Forecast, by Application (2019-2030)
12.4.6.4. Market Revenue and Forecast, by End User (2019-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.7.2. Market Revenue and Forecast, by Route of Administration (2019-2030)
12.4.7.3. Market Revenue and Forecast, by Application (2019-2030)
12.4.7.4. Market Revenue and Forecast, by End User (2019-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.8.2. Market Revenue and Forecast, by Route of Administration (2019-2030)
12.4.8.3. Market Revenue and Forecast, by Application (2019-2030)
12.4.8.4. Market Revenue and Forecast, by End User (2019-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.2. Market Revenue and Forecast, by Route of Administration (2019-2030)
12.5.3. Market Revenue and Forecast, by Application (2019-2030)
12.5.4. Market Revenue and Forecast, by End User (2019-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.5.2. Market Revenue and Forecast, by Route of Administration (2019-2030)
12.5.5.3. Market Revenue and Forecast, by Application (2019-2030)
12.5.5.4. Market Revenue and Forecast, by End User (2019-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.6.2. Market Revenue and Forecast, by Route of Administration (2019-2030)
12.5.6.3. Market Revenue and Forecast, by Application (2019-2030)
12.5.6.4. Market Revenue and Forecast, by End User (2019-2030)
Chapter 13. Company Profiles
13.1. Johnson & Johnson
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Novartis International AG
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. F. Hoffmann-La Roche AG
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Pfizer Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Bayer AG
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Antares Pharma, Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. GlaxoSmithKline plc
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. 3M (US), Merck & Co., Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Sanofi
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Amgen, Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1561
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
0 Comments